These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3285417)

  • 1. Anatomic markers of human mammary premalignancy and incipient breast cancer.
    Page DL
    Recent Results Cancer Res; 1988; 106():65-72. PubMed ID: 3285417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thermography in the diagnosis of benign breast diseases].
    Lauth G; Duda V; Thein T
    Gynakologe; 1989 Aug; 22(4):242-5. PubMed ID: 2792912
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

  • 7. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomorphometric diagnosis of dysplasias during dyshormonal and hyperplastic processes in the mammary gland].
    Volchenko NN; Medovyĭ VS; Klimova NV; Slavnova EN; Savostikova MV
    Klin Lab Diagn; 2006 May; (5):52-4. PubMed ID: 16827243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R; Werner J
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract]   [Full Text] [Related]  

  • 12. Benign breast disease and cancer risk.
    Bianchi S; Palli D; Galli M; Zampi G
    Crit Rev Oncol Hematol; 1993 Dec; 15(3):221-42. PubMed ID: 8142058
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
    Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision?
    Dershaw DD
    Breast J; 2003; 9(1):1-3. PubMed ID: 12558662
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY; Khairy GA
    Saudi Med J; 2004 Dec; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breast: tissue changes and cancer risk.
    Sinclair RA
    Med J Aust; 1988 Oct; 149(8):424-6. PubMed ID: 3173205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.